Denali Therapeutics was founded in 2015 by world-renowned scientists and biotech leaders with a shared vision of reversing the course of devastating diseases by creating transformative medicines. The company combines scientific, medical and drug development expertise with a deep understanding of the genetic and molecular causes of disease, enabling the development of precision medicines designed to treat the underlying causes of neurologic disorders.
